Sign in
Biotech
Medtech
Pharma
Public Health
Real Estate
Events
Home
Sign in
Welcome!
Log into your account
your username
your password
Forgot your password?
Password recovery
Recover your password
your email
Search
Saturday, October 24, 2026
Advertising
About Us
Subscribe to Newsletter
Facebook
X
Youtube
Biotech
Medtech
Pharma
Public Health
Real Estate
Events
Home
Search
Home
Venture Capital
Venture Capital
Venture Capital
Estuary Biotherapeutics Launches with $103 Million to Advance Gene Therapies for Kidney Disease
Life Sciences Times
-
October 16, 2026
Venture Capital
Acta Pharmaceuticals Raises $24 Million to Advance Alzheimer’s Disease Treatments
Life Sciences Times
-
October 15, 2026
Venture Capital
Soufflé Therapeutics Raises $135 Million in Series B Financing to Advance RNA Therapies
Life Sciences Times
-
October 13, 2026
Venture Capital
Consano Bio Raises More Than $15 Million to Advance Chronic Sciatica Therapy
Life Sciences Times
-
October 5, 2026
Venture Capital
ai3Bio Launches With $48 Million Series A to Advance Autoimmune Disease Therapies
Life Sciences Times
-
September 29, 2026
Venture Capital
Symphony RetailAI Acquires Shelf Intelligence SaaS Technology Leader ReTech Labs
Life Sciences Times
-
October 27, 2021
0
Venture Capital
InCloudCounsel Announces $200 Million Series B Funding from Blackstone Growth (BXG), Rebrands as Ontra
Life Sciences Times
-
October 27, 2021
0
Venture Capital
Takeda to Acquire GammaDelta Therapeutics to Accelerate Development of Allogeneic γδT Cell Therapies Addressing Solid Tumors
Life Sciences Times
-
October 27, 2021
0
Venture Capital
DNA Script Raises $165M in Oversubscribed Series C Financing to Accelerate Commercialization of Enzymatic DNA Printing Platform
Life Sciences Times
-
October 26, 2021
0
Venture Capital
Sofinnova Partners Congratulates Portfolio Company DNA Script for the Success of Its €142M ($165M) Oversubscribed Series C Fundraise
Life Sciences Times
-
October 26, 2021
0
Venture Capital
SimBioSys Raises $15 Million Series A to Develop the Future of Precision Cancer Care
Life Sciences Times
-
October 26, 2021
0
Venture Capital
Medable Secures $304 Million in Funding at $2.1 Billion Valuation; New Round Co-Led by Blackstone Growth, GSR Ventures and Tiger Global
Life Sciences Times
-
October 26, 2021
0
Venture Capital
Egle Therapeutics Raises 40 Million € Series a to Develop First-In-Class T-regulatory Cells Therapies Based On Treg-starvers
Life Sciences Times
-
October 22, 2021
0
Venture Capital
ReCode Therapeutics Raises Oversubscribed Series B Financing Round of $80 Million
Life Sciences Times
-
October 21, 2021
0
Venture Capital
ShouTi Secures $100 Million Series B Financing to Accelerate Development of Life-Changing Medicines
Life Sciences Times
-
October 20, 2021
0
Venture Capital
Marc Schneebaum Joins Avalyn Pharma as Chief Financial Officer
Life Sciences Times
-
October 20, 2021
0
Venture Capital
Carlyle and Leading Healthcare-Focused Venture Funds Announce Strategic Growth Investment of up to $430 Million in Saama
Life Sciences Times
-
October 20, 2021
0
1
...
95
96
97
...
115
Page 96 of 115
Most Read
Alnylam Reports Promising Phase 1b Results for Experimental Huntington’s Disease Treatment
October 23, 2026
Zai Lab Reports Promising Early Results for Experimental Small Cell Lung Cancer Treatment
October 23, 2026
Takeda Reports Improved Survival in Phase 3 Trial of Experimental Gastric Cancer Treatment
October 23, 2026
Convergent Therapeutics Reports Promising Phase 2 Results for Prostate Cancer Treatment
October 23, 2026